"CONCLUSIONS
Patients with heart failure and a preserved ejection fraction who received isosorbide mononitrate were less active and did not have better quality of life or submaximal exercise capacity than did patients who received placebo. (Funded by the National Heart, Lung, and Blood Institute; ClinicalTrials.gov number, NCT02053493.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1510774?query=featured_home
No comments:
Post a Comment